Blog
Pearl Pathways’ Bowker leads webinar
On August 8, 2013, Gretchen Bowker, co-founder and COO of Pearl Pathways, will host a webinar on ComplianceOnline.com reviewing the similarities and differences in the regulatory paths and requirements for drugs, biologics and medical devices. It will discuss the...
Ellen Looney featured in GCP training Webinar
Do you work at a site as a clinical research coordinator and need a deeper dive into Good Clinical Practices (GCPs)? Are you a sponsor who has responsibility for oversight and training of site personnel? On July 26, 2013, Pearl Pathways’ own Ellen Looney will lead a...
Pathways’ Bowker leads FDA supplier audit webinar
Are you a supplier of raw materials, component parts or finished product to biopharma or medical device companies? The supply chain for pharmaceuticals, biologics and medical device companies are increasingly being audited by their clients and FDA. On July 25, 2013,...
EMA Draft transparency policy open to public for comments
An article posted on clindev.eu shares that the European Medicines Agency (EMA) has announced a three month public consultation of a draft transparency policy regarding clinical trial information. EMA is hoping to launch the policy in early 2014. Potential threats to...
Successful open house for Pearl Pathways
Pearl Pathways’ open house last Thursday the 20th welcomed in the new office with a bang. The afternoon get together was a fun way for visitors to stop by and see the new place. A refurnished interior to an old Indianapolis building on the south side of the city...